Semaglutide, the active ingredient in Ozempic and Wegovy, reduces appetite and slows stomach emptying through GLP-1 receptor activation
(10 pts) Oxidant Reductant RE(V) Succinate -CO a-ketoglutarate 2 -0.67 Acetate Acetaldehyde 2 0.60 Ferredokan (oxidized) Ferredoxin (reduced) 1 -043 2 H HE 2 042 NAD: NADH-H 2 -0.32 NADP NADPH-H 2 -0.32 Lipoate oxidured) Lipoate reduced 2 -0.29 Glutathione (oxidized) Glutathione (reduced) 2 03 EAD EADH 2022 Acetaldehyde Ethanol 2030 Pyruvate Lactate 2 019 Fumarate Succinate 003 Cytochrome (+3) Cytochrome (+2) 0.07 Dehydroascorbate Ascorbate 2 0.08 Ubiquinone (oxidured) Ubiquinone (reduced) 2 010 Cytochronne(+3) Cytochrome (2) 0.22 Fe(+3) Fe (-2) 0.77 02-27 HO 2 2 1
Starting with a 0.25 mg dose, patients typically increase their dose every 4 weeks until they reach a maintenance dose of 0.5 mg, 1.0 mg, or 2.0 mg, depending on their individual glycemic control needs
Clearly, evidence is accumulating that semaglutide is associated with a lower risk of heart disease and stroke in diabetics and those who are obese with cardiovascular diseases, Dr
, Ozempic Highlights of Prescribing Information (Jan
